Posted 13 May 2024
SVI was thrilled to recently host representatives from the Lions Australia Diabetes Foundation and Lions Club. We are immensely grateful for their generous contributions toward acquiring the IncuCyte Live Cell Imaging Platform, a cutting-edge tool that will significantly enhance our diabetes research efforts.
In addition to this invaluable support, Lions Victoria District 201 V1-4 and Lions International Foundation US, contributed a substantial contribution, totalling $195,000. This brings the overall commitment to $220,000, towards the instrument’s purchase.
The IncuCyte Live Cell Imaging Platform allows researchers to monitor living cells in real-time, providing unprecedented insights into cellular behaviours and interactions. For diabetes research, this technology is transformative. It enables us to observe the effects of various treatments on insulin-producing beta cells, which are crucial for developing new therapies. By continuously tracking cell health, growth, and responses to interventions, the IncuCyte offers detailed data that can lead to more effective and personalised treatment strategies.
With the support of the Lions community, our researchers are now equipped with the tools needed to make groundbreaking advances in diabetes research. This investment not only accelerates our understanding of the disease but also brings us closer to innovative solutions. We extend our sincere thanks to the Lions Australia Diabetes Foundation, Lions Victoria District 201 V1-4, and Lions International Foundation US for their exceptional generosity and commitment to this vital cause.